Objective: This study investigated the distribution of second-formant (F2) slopes in a relatively large number of speakers with dysarthria associated with two different underlying diseases. Patients and Methods: Forty speakers with dysarthria (20 with Parkinson’s disease, PD; 20 with stroke) and 5 control speakers without a history of neurological disease were asked to repeat six words (coat, hail, sigh, shoot, row and wax) 10 times. Acoustic analysis was performed to derive F2 slope, and speech intelligibility data were collected using a direct magnitude estimate technique to examine its relationship to F2 slope. Results: Statistical analysis revealed that both clinical groups showed significantly reduced F2 slopes compared to healthy speakers for all words but row. No group difference was found between speakers with PD and stroke; however, different words showed varying sensitivity to the speech motor control problems. The F2 slopes of only two words, shoot and wax, were significantly correlated with scaled speech intelligibility. Conclusion: The findings support the idea that distributional characteristics of acoustic variables, such as F2 slope, could be used to develop a quantitative metric of severity of speech motor control deficits in dysarthria, when the materials are appropriately selected and additional distributional characteristics are studied.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.